Temasek Holdings (Private) Ltd 13D and 13G filings for Beam Therapeutics Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-02-06 07:27 am Sale | 2023-12-31 | 13G | Beam Therapeutics Inc. BEAM | Temasek Holdings (Private) Ltd | 3,076,117 3.800% | -568,456 (-15.60%) | Filing |
| 2023-03-17 06:04 am Purchase | 2023-03-09 | 13G | Beam Therapeutics Inc. BEAM | Temasek Holdings (Private) Ltd | 3,644,573 5.000% | 766,276 (+26.62%) | Filing |
| 2023-02-10 06:10 am Sale | 2022-12-31 | 13G | Beam Therapeutics Inc. BEAM | Temasek Holdings (Private) Ltd | 2,878,297 4.100% | -1,080,915 (-27.30%) | Filing |
| 2022-02-14 06:38 am Purchase | 2021-12-31 | 13G | Beam Therapeutics Inc. BEAM | Temasek Holdings (Private) Ltd | 3,959,212 5.800% | 604,571 (+18.02%) | Filing |
| 2021-02-05 06:06 am Purchase | 2020-02-06 | 13G | Beam Therapeutics Inc. BEAM | Temasek Holdings (Private) Ltd | 3,354,641 5.700% | 3,354,641 (New Position) | Filing |